Kretschmer L, Ruhnke L, Schliemann C, Fransecky L, et al. VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML. Ann Hematol 2025;104:3647-3654.
PMID: 40629154